Status:
WITHDRAWN
Contrast Enhanced Endoscopic Ultrasound for Vascular Involvement in Pancreatic Lesions
Lead Sponsor:
University of Vermont
Conditions:
Pancreatic Tumors
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
In the US, pancreas cancer is the fifth leading cause of cancer related deaths. It was estimated to have taken 36,800 lives in 2010. Unfortunately, curing pancreatic cancer requires surgical removal. ...
Detailed Description
1. CT Scan of the abdomen - Standard Therapy a. The standard of care is that patients in question of pancreatic lesions undergo CT scanning. After a CT scan, if it appears that the pancreatic mass...
Eligibility Criteria
Inclusion
- Patient with pancreatic lesion undergoing EUS for diagnosis and pre-operative assessment.
Exclusion
- Pregnant women, breastfeeding women and individuals with metastatic lesions on CT.
Key Trial Info
Start Date :
July 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2013
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01526590
Start Date
July 1 2012
End Date
July 1 2013
Last Update
June 4 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fletcher Allen Healthcare
Burlington, Vermont, United States, 05401